Altered Release of Tumor Necrosis Factor and Its Soluble Receptor in Non-Hodgkin's Lymphoma Patients-Reference-Cited by-同舟云学术

Altered Release of Tumor Necrosis Factor and Its Soluble Receptor in Non-Hodgkin's Lymphoma Patients

Published:1999-05 Issue:3 Volume:23 Page:226-231
ISSN:0361-090X
Container-title:Cancer Detection Prevention
language:en
Short-container-title:Cancer Detect Prev

Author:

Rathore Vipul B.,Advani Suresh H.,Nadkarni Jayshree J.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1525-1500.1999.99024.x/fullpdf

Reference23 articles.

1. 1BA Peterson, and CD Bloomfield . Non-Hodgkin's malignant lymphomas. In: Greenspan EM, ed. Interpretation and practice of cancer chemotherapy. New York: Raven Press; 1982 :519.

2. Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia

3. EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER

4. Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of Body Mass Index on Survival in Veterans With Multiple Myeloma;The Oncologist;2013-09-18

2. A Review of the Intravenous Administration of Radiolabeled Immunoglobulin G to Cancer Patients. High or Low Protein Dose?;Cancer Biotherapy and Radiopharmaceuticals;2003-02

3. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II;British Journal of Haematology;2000-12

4. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II;British Journal of Haematology;2000-12

5. HIGH CYTOSOLIC POOL OF p75 TNF RECEPTORS AND DELAYED SURFACE DOWNMODULATION BY MONONUCLEAR CELLS FROM NON-HODGKIN'S LYMPHOMA PATIENTS;Cytokine;2000-07